The Ets-1 transcription factor is required for the development of natural killer cells in mice

Immunity

Volumn 9, Issue 4, 1998, Pages 555-563

  Barton, Kevin ^a,c   Muthusamy, Natarajan ^a   Fischer, Christopher ^a   Ting, Chao Nan ^a   Walunas, Theresa L ^a   Lanier, Lewis L ^b   Leiden, Jeffrey M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; IMMUNOGLOBULIN M; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 2 RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CYTOLYSIS; CYTOTOXICITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; TRANSCRIPTION REGULATION;

EID: 0032191918     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80638-X     Document Type: Article

References (37)

1. Bancroft, G.J. (1993). The role of natural killer cells in the innate resistance to infection. Curr. Opin. Immunol. 5, 503-510.
2. Bassuk, A.G., and Leiden, J.M. (1997). The role of Ets transcription factors in the development and function of the mammalian immune system. Adv. Immunol. 64, 65-104.
3. Biron, C.A. (1997). Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9, 24-34.
4. Bories, J.-C., Willerford, D.M., Grevin, D., Davidson, L., Camus, A., Martin, P., Stehelin, D.,and Alt, F.W. (1995). Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature 377, 635-638.
5. Carlyle, J.R., Michie, A.M., Furlonger, C., Nakano, T., Lenardo, M.J., Paige, C.J., and Zuniga-Pflucker, J.C. (1997). Identification of a novel developmental stage marking lineage commitment of progenitor thymocytes. J. Exp. Med. 186, 173-182.
6. Carson, W.E., Fehniger, T.A., Haldar, S., Eckhert, K., Lindemann, M.J., Lai, C.F., Croce, C.M., Baumann, H., and Caligiuri, M.A. (1997). A potential role for interleukin-15 in the regulation of human natural killer cell survival. J. Clin. Invest. 99, 937-943.
7. Chan, S.H., Kobayashi, M., Santoli, D., Perussia, B., and Trinchieri, G. (1992). Mechanisms of IFNγ induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J. Immunol. 148, 92-98.
8. Crepieux, P., Coll, J., and Stehelin, D. (1994). The Ets family of proteins: weak modulators of gene expression in quest for transcriptional partners. Crit. Rev. Oncog. 5, 615-638.
9. DiSanto, J.P., Muller, W., Guy-Grand, D., Fischer, A., and Rajewsky, K. (1995). Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc. Natl. Acad. Sci. USA 92, 377-381.
10. Donaldson, L.W., Peterson, J.M., Graves, B.J., and McIntosh, L.P. (1996). Solution structure of the ETS domain from murine Ets-1: a winged helix-turn-helix DNA binding motif. EMBO J. 15, 125-143.
11. Georgopoulos, K., Bigby, M., Wang, J.H., Molnar, A., Wu, P., Winandy, S., and Sharpe, A. (1994). The Ikaros gene is required for the development of all lymphoid lineages. Cell 79, 143-156.
12. Gumperz, J.E., and Parham, P. (1995). The enigma of the natural killer cell. Nature 378, 245-248.
13. Kalland,T. (1986). Generation of natural killer cells from bone marrow precursors in vitro. Immunology 57, 493-498.
14. Karre, K., Ljunggren, H.J., Piontek, G., and Kiessling, R. (1986). Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675-678.
15. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R.M., Clark, S.C., Chan, S., Loudon, R., Sherman, F., Perussia, B., and Trinchieri, G. (1989). Identification and purification of natural killer cell stimulatory factor (NKSF), acytokinewith multiple biological effects on human lymphocytes. J. Exp. Med. 170, 827-845.
16. Lanier, L.L. (1997). Natural killer cells: from no receptors to too many. Immunity 6, 371-378.
17. Lanier, L.L. (1998). Follow the leader: NK cell receptors for classical and nonclassical MHC class I. Cell 92, 705-707.
18. Lanier, L.L., Corliss, B.C., Wu, J., Clement, L., and Phillips, J.H. (1998). Immunoreceptor DAP12 bearing atyrosine-based activation motif is involved in activating NK cells. Nature 391, 703-707.
19. Leibson, P.J. (1997). Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 6, 655-661.
20. Liao, N.-S., Bix, M., Kijlstra, M., Jaenisch, R., and Raulet, D. (1991). MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253, 199-202.
21. Magram, J., Connaughton, S.E., Warrier, R.R., Carvajal, D.M., Wu, C.Y., Ferrante, J., Stewart, C., Sarmiento, U., Faherty, D.A., and Gately, M.K. (1996). IL-12-deficient mice are defective in IFNγ production and type 1 cytokine responses. Immunity 4, 471-481.
22. Moore, T.A., Bennett, M., and Kumar, V. (1996). Murine natural killer cell differentiation: past, present and future, Immunol. Res. 15, 151-162.
23. Murphy, W.J., Reynolds, C.W., Tiberghien, P., and Longo, D.L. (1993). Natural killer cells and bone marrow transplantation. J. Natl. Cancer Inst. 85, 1475-1482.
24. Muthusamy, N., Barton, K., and Leiden, J.M. (1995). Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature 377, 639-642.
25. Ogasawara, K., Hida, S., Azimi, N., Tagaya, Y., Sato, T., Yokochi-Fukuda, T., Waldmann, T.A., Taniguchi, T., and Taki, S. (1998). Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391, 700-703.
26. Ohlen, C., Kling, G., Hoglund, P., Hansson, M., Scangos, G., Bieberich, C., Jay, G., and Karre, K. (1989). Prevention of allogeneic bone marrow graft rejection by H-2transgene in donor mice. Science 246, 666-668.
27. Puzanov, I.J., Bennett, M., and Kumar, V. (1996). IL-15 can substitute for the marrow microenviroment in the differentiation of natural killer cells. J. Immunol. 157, 4282-4285.
28. Qian, D., and Weiss, A. (1997). T cell antigen receptor signal transduction. Curr. Opin. Cell Biol. 9, 205-212.
29. Rodewald, H.-R., Moingeon, P., Lucich, J.L., Dosoiu, C., Lopez, P., and Reinherz, E.L. (1992). A population of early fetal thymocytes expressing FcgRII/III precursors of T lymphocytes and natural killer cells. Cell 69, 139-150.
30. Sanchez, M.J., Muench, M.O., Roncarolo, M.G., Lanier, L.L., and Phillips, J.H. (1994). Identification of a common T/natural killer cell progenitor in human fetal thymus. J. Exp. Med. 180, 569-576.
31. Su, G.H., Chen, H.-M., Muthusamy, N., Garrett-Sinha, L.A., Tenen, D.G, and Simon, M.C. (1997). Disruption of the gene encoding Spi-B, an Ets protein causes defective B cell receptor mediated responses. EMBO J. 16, 7118-7129.
32. Suzuki, H., Duncan, G.S., Takimoto, H., and Mak, T.W. (1997). Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor β chain. J. Exp. Med. 185, 499-505.
33. Takeda, K., Tsutsui, H., Yoshimoto, T., Adachi, O., Yoshida, N., Kishimoto, T., Okamura, H., Nakanishi, K., and Akira, S. (1998). Defective NK cell activity and TH1 response in IL-18-deficient mice. Immunity 8, 383-390.
34. Trinchieri, G. (1989). Biology of natural killer cells. Adv. Immunol. 47, 187-376.
35. van den Broek, M.F., Kagi, D., Zinkernagel, R.M., and Hengartner, H. (1995). Perforin dependence of natural killer cell-mediated tumor control in vivo. Eur. J. Immunol. 25, 3514-3516.
36. Yu, Y.Y.L., Kumar, V., and Bennett, M. (1992). Murine natural killer cells and marrow graft rejection. Annu. Rev. Immunol. 10, 189-213.
37. Zuniga-Pflucker, J.C., and Lenardo, M.J. (1996). Regulation of thymocyte development from immature progenitors. Curr. Opin. Immunol. 8, 215-224.